(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1643510

患者エンゲージメントにおける人工知能の世界市場

Artificial Intelligence in Patient Engagement

出版日
ページ情報
英文 248 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
患者エンゲージメントにおける人工知能の世界市場
出版日: 2025年01月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 248 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

患者エンゲージメントにおける人工知能の世界市場は2030年までに231億米ドルに達する見込み

2024年に80億米ドルと推定される患者エンゲージメントにおける人工知能の世界市場は、2024年から2030年にかけてCAGR 19.4%で成長し、2030年には231億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるクラウドベースのデリバリーモードは、CAGR 21.7％を記録し、分析期間終了時には184億米ドルに達すると予測されます。オンプレミス配信モードセグメントの成長率は、分析期間中CAGR 12.8%と推定されます。

米国市場は21億米ドル、中国はCAGR18.3％で成長すると予測

米国の患者エンゲージメントにおける人工知能市場は、2024年に21億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに35億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは18.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ18.0％と16.4％と予測されています。欧州では、ドイツがCAGR約13.0％で成長すると予測されています。

世界の患者エンゲージメントにおける人工知能市場- 主要動向と促進要因まとめ

AIは患者エンゲージメントをどのように変革するか？

人工知能（AI）は、パーソナライズされたケアを提供し、コミュニケーションを改善し、患者が健康管理に積極的な役割を果たせるようにすることで、患者エンゲージメントに革命をもたらしています。従来の患者エンゲージメントの手法は、しばしば手作業によるやり取りや標準化されたアプローチに依存しており、個々のニーズに効果的に対応することができませんでした。AIは、機械学習（ML）、自然言語処理（NLP）、予測分析を活用してこれらの課題に対処し、カスタマイズされた有意義な患者体験を実現します。

AIを搭載したチャットボットやバーチャルアシスタントは、24時間365日のサポートを提供し、患者からの問い合わせに答えたり、予約のスケジューリングをしたり、投薬のリマインダーを送信したりします。これらのツールは、ヘルスケア提供者の管理負担を軽減しながら、アクセシビリティを向上させます。さらに、AIシステムは患者データを分析し、パーソナライズされた健康提案を提供することで、エンゲージメント戦略が個人の嗜好や病歴に合致するようにします。

さらにAIは、モバイルアプリやポータル、ウェアラブル端末を通じてカスタマイズされたコンテンツを提供することで、患者教育を強化します。これらのプラットフォームは、健康状態、治療オプション、ライフスタイルの変化に関する洞察を提供し、情報に基づいた意思決定を促します。継続的かつコンテキストを意識したエンゲージメントを可能にすることで、AIは患者とヘルスケアサービスとの関わり方を変えつつあります。

患者エンゲージメントにおけるAI導入の原動力とは？

パーソナライズされた効率的なヘルスケア体験に対する需要の高まりが、患者エンゲージメントにおけるAI導入の大きな原動力となっています。患者が独自のニーズに対応するカスタマイズされたケアを求める傾向が強まる中、AIを活用したソリューションは、満足度とアウトカムを高めるオーダーメイドのコミュニケーションとサポートを提供します。これらのツールは、デジタルに精通した個人から、より多くのガイダンスを必要とする個人まで、多様な患者の嗜好に対応しています。

遠隔医療や遠隔診療モデルの台頭も、AIの導入に拍車をかけています。バーチャル診察が普及する中、AI主導のプラットフォームは、セルフモニタリング、症状追跡、バーチャルフォローアップのためのツールを患者に提供することで、ギャップを埋めています。このような機能により、遠隔地や十分なサービスを受けられない地域の患者のアクセスを改善しながら、ケアの継続性を確保することができます。

さらに、データ統合と相互運用性の進歩により、AIシステムは複数のタッチポイントにわたってシームレスな患者エンゲージメントを提供できるようになっています。電子カルテ（EHR）、ウェアラブル端末、健康アプリのデータを分析することで、AIは患者のペイシェントジャーニーを統一的に把握し、一貫性のあるインパクトのあるインタラクションを実現します。これらの動向は、患者エンゲージメント戦略を再構築する上でAIの重要性が高まっていることを裏付けています。

AIは健康アウトカムと患者満足度を高めることができるか？

AIは、プロアクティブでパーソナライズされたケアを促進することで、健康アウトカムと患者満足度を大幅に向上させています。予測分析ツールは、慢性疾患や合併症のリスクのある患者を特定し、タイムリーな介入を可能にし、入院の可能性を減らします。例えば、AIシステムはバイタルサインやライフスタイルデータを監視し、糖尿病や心臓病などの疾患の早期警告サインを検出することで、ヘルスケアプロバイダーが予防措置を講じることを可能にします。

ルーチン・タスクを自動化し、ケア・コーディネーションを改善することで、AIはしばしば患者の不満につながる管理上の非効率性を軽減します。リアルタイムの最新情報、自動予約リマインダー、医療情報への容易なアクセスにより、患者は常に情報を入手し、ケアに参加することができます。このような機能により、患者の全体的なエクスペリエンスが向上し、治療計画の遵守率が高まります。

AIはまた、ストレス管理、マインドフルネス、行動療法のためのツールを提供することで、メンタルヘルスとウェルビーイングをサポートします。バーチャル・アシスタントは、患者ケアの感情的な側面に対応し、パーソナライズされた推奨事項や対処戦略を提供します。こうした技術革新は全人的な健康管理に貢献し、身体的・精神的な幸福を向上させる。

患者エンゲージメントにおけるAI市場の成長の原動力は？

患者エンゲージメントにおける人工知能市場の成長は、ヘルスケアにおける変革の可能性を反映したいくつかの重要な要因によって牽引されています。患者中心のケアモデルへの注目が高まる中、ヘルスケアプロバイダーは、コミュニケーションを改善し、パーソナライズされた体験を提供するAIツールの導入を促しています。これらのソリューションは、組織が患者とのより強い関係を構築し、忠誠心と信頼を高めるのに役立ちます。

機械学習、NLP、リアルタイム分析などのAIの技術的進歩は、患者エンゲージメント・プラットフォームの機能を拡張しています。これらのツールは、ヘルスケアプロバイダーが患者のニーズを予測し、プロアクティブなサポートを提供できるようにする実用的な洞察を提供します。

デジタルヘルスソリューションへの嗜好の高まりなど、消費者の行動動向は市場成長をさらに後押ししています。患者は、モバイルアプリ、ウェアラブルデバイス、バーチャルアシスタントを、健康を効果的に管理するツールとして受け入れています。さらに、バリュー・ベース・ケアや患者エンゲージメント・イニシアチブを促進する規制上のインセンティブが、ヘルスケアにおけるAIの採用を後押ししています。

これらの要因は、デジタルヘルス技術への投資の増加と相まって、患者エンゲージメントにおけるAI市場の急速な拡大を後押ししており、医療提供と患者中心のサービスにおける将来の革新の礎石として位置付けられています。

セグメント

提供形態（クラウドベースの提供形態、オンプレミスの提供形態）、機能性（コミュニケーション強化機能、チャットボット＆バーチャルヘルスアシスタント機能、予測分析機能、患者教育機能、その他の機能性）、技術（自然言語処理（NLP）技術、その他の技術）、治療領域（慢性疾患管理治療領域、ヘルス＆ウェルネス治療領域、その他の治療領域）、エンドユーザー（ヘルスケアプロバイダエンドユーザー、ヘルスケアペイヤーエンドユーザー、その他のエンドユーザー）

調査対象企業の例（注目の52社）

  • Ada Health GmbH
  • AiCure
  • Aiva
  • AllazoHealth
  • Brand Engagement Network, Inc.
  • Claritas Rx
  • EmpiRx Health, LLC.
  • Health Catalyst
  • Huma
  • IBM Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP29263

Global Artificial Intelligence in Patient Engagement Market to Reach US$23.1 Billion by 2030

The global market for Artificial Intelligence in Patient Engagement estimated at US$8.0 Billion in the year 2024, is expected to reach US$23.1 Billion by 2030, growing at a CAGR of 19.4% over the analysis period 2024-2030. Cloud-based Delivery Mode, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach US$18.4 Billion by the end of the analysis period. Growth in the On-Premise Delivery Mode segment is estimated at 12.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 18.3% CAGR

The Artificial Intelligence in Patient Engagement market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.5 Billion by the year 2030 trailing a CAGR of 18.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.0% and 16.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Artificial Intelligence in Patient Engagement Market - Key Trends & Drivers Summarized

How Is AI Transforming Patient Engagement?

Artificial Intelligence (AI) is revolutionizing patient engagement by delivering personalized care, improving communication, and empowering patients to take an active role in their health management. Traditional patient engagement methods often rely on manual interactions and standardized approaches that fail to address individual needs effectively. AI addresses these challenges by leveraging machine learning (ML), natural language processing (NLP), and predictive analytics to create tailored and meaningful patient experiences.

AI-powered chatbots and virtual assistants provide 24/7 support, answering patient queries, scheduling appointments, and sending medication reminders. These tools enhance accessibility while reducing the administrative burden on healthcare providers. In addition, AI systems analyze patient data to offer personalized health recommendations, ensuring that engagement strategies align with individual preferences and medical histories.

Moreover, AI enhances patient education by delivering customized content through mobile apps, portals, and wearable devices. These platforms provide insights into health conditions, treatment options, and lifestyle changes, fostering informed decision-making. By enabling continuous and context-aware engagement, AI is transforming the way patients interact with healthcare services.

What Drives the Adoption of AI in Patient Engagement?

The growing demand for personalized and efficient healthcare experiences is a major driver of AI adoption in patient engagement. As patients increasingly seek customized care that addresses their unique needs, AI-powered solutions offer tailored communication and support that enhances satisfaction and outcomes. These tools cater to diverse patient preferences, from digital-savvy individuals to those requiring more guidance.

The rise of telemedicine and remote care models is also fueling AI adoption. With virtual consultations becoming more prevalent, AI-driven platforms bridge the gap by providing patients with tools for self-monitoring, symptom tracking, and virtual follow-ups. These capabilities ensure continuity of care while improving access for patients in remote or underserved areas.

Additionally, advancements in data integration and interoperability are enabling AI systems to provide seamless patient engagement across multiple touchpoints. By analyzing data from electronic health records (EHRs), wearable devices, and health apps, AI creates a unified view of the patient journey, ensuring consistent and impactful interactions. These trends underscore the growing importance of AI in reshaping patient engagement strategies.

Can AI Enhance Health Outcomes and Patient Satisfaction?

AI is significantly enhancing health outcomes and patient satisfaction by fostering proactive and personalized care. Predictive analytics tools identify patients at risk of chronic conditions or complications, enabling timely interventions and reducing the likelihood of hospitalizations. For example, AI systems monitor vital signs and lifestyle data to detect early warning signs of conditions such as diabetes or heart disease, allowing healthcare providers to take preventive action.

By automating routine tasks and improving care coordination, AI reduces administrative inefficiencies that often lead to patient dissatisfaction. Real-time updates, automated appointment reminders, and easy access to medical information empower patients to stay informed and engaged in their care. These capabilities enhance the overall patient experience while ensuring better adherence to treatment plans.

AI also supports mental health and well-being by providing tools for stress management, mindfulness, and behavioral therapy. Virtual mental health assistants deliver personalized recommendations and coping strategies, addressing the emotional aspects of patient care. These innovations contribute to holistic health management, improving both physical and mental well-being.

What’s Driving the Growth of the AI in Patient Engagement Market?

The growth in the Artificial Intelligence in Patient Engagement market is driven by several critical factors, reflecting its transformative potential in healthcare. The increasing focus on patient-centric care models is encouraging healthcare providers to adopt AI tools that improve communication and deliver personalized experiences. These solutions help organizations build stronger relationships with patients, enhancing loyalty and trust.

Technological advancements in AI, including machine learning, NLP, and real-time analytics, are expanding the capabilities of patient engagement platforms. These tools provide actionable insights that enable healthcare providers to anticipate patient needs and deliver proactive support.

Consumer behavior trends, such as the growing preference for digital health solutions, are further driving market growth. Patients are embracing mobile apps, wearable devices, and virtual assistants as tools to manage their health effectively. Additionally, regulatory incentives promoting value-based care and patient engagement initiatives are supporting the adoption of AI in healthcare.

These factors, coupled with increasing investments in digital health technologies, are propelling the rapid expansion of the AI in Patient Engagement market, positioning it as a cornerstone of future innovation in healthcare delivery and patient-centric services.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence in Patient Engagement market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Delivery Mode (Cloud-based Delivery Mode, On-Premise Delivery Mode); Functionality (Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality, Other Functionalities); Technology (Natural Language Processing (NLP) Technology, Other Technologies); Therapeutic Area (Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area, Other Therapeutic Areas); End-Use (Healthcare Providers End-Use, Healthcare Payers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 52 Featured) -

  • Ada Health GmbH
  • AiCure
  • Aiva
  • AllazoHealth
  • Brand Engagement Network, Inc.
  • Claritas Rx
  • EmpiRx Health, LLC.
  • Health Catalyst
  • Huma
  • IBM Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Artificial Intelligence in Patient Engagement - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Real-Time AI Chatbots Expand Opportunities for Enhancing Patient Communication
    • AI for Personalized Health Recommendations Strengthens Case for Proactive Engagement
    • AI-Driven Virtual Health Assistants Spur Growth in Home-Based Care Models
    • AI for Appointment Scheduling Optimizes Patient Flow, Driving Market Adoption
    • AI in Medication Adherence Monitoring Highlights Opportunities in Chronic Disease Management
    • AI-Powered Health Education Platforms Expand Addressable Market for Wellness Apps
    • Growing Demand for AI in Telehealth Sets the Stage for Patient-Centric Engagement Tools
    • AI for Remote Monitoring Systems Strengthens Case for Continuous Patient Interaction
    • AI for Multilingual Support Tools Bodes Well for Global Patient Engagement Markets
    • Integration of AI in Family Health Management Strengthens Use Cases in Collaborative Care
    • AI for Seamless Billing and Insurance Queries Drives Adoption in Revenue Cycle Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence in Patient Engagement Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cloud-based Delivery Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Cloud-based Delivery Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for On-Premise Delivery Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for On-Premise Delivery Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chronic Disease Management Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Chronic Disease Management Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Health & Wellness Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Health & Wellness Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Healthcare Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Healthcare Providers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Healthcare Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Healthcare Payers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Enhanced Communication Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Enhanced Communication Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Chatbots & Virtual Health Assistants Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Chatbots & Virtual Health Assistants Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Predictive Analytics Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Predictive Analytics Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Patient Education Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Patient Education Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Functionalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Other Functionalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Natural Language Processing (NLP) Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Natural Language Processing (NLP) Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 64: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 70: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 72: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 84: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 88: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 90: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 94: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 96: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 100: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 102: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • ITALY
    • TABLE 106: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 108: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 112: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 114: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 118: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 120: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 124: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 132: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 142: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 144: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 148: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 150: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 154: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 155: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030

IV. COMPETITION